Multi-centric, retrospective analysis of the diagnostic value of cardiovascular magnetic resonance imaging in amyloidsis in comparison to endomyocardial biopsy

Multi-centric, retrospective analysis of the diagnostic value of cardiovascular magnetic resonance imaging in amyloidsis in comparison to endomyocardial biopsy - CMR-vs-Biopsy-in-Amyloid

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022319

Enrollment

200

Registered

2020-07-09

Start date

2020-03-13

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E85.4

Interventions

Group 1: Patients with suspected cardiac amyloidosis receive a cardiac MRI examination to confirm the diagnosis. If the MRI result is positive, an endomyocardial biopsy is taken and examined for amylo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: MRI series since 01/01/2016

Exclusion criteria

Exclusion criteria: GFR < 30 ml/min/1,73m2

Design outcomes

Primary

Measure	Time frame
Observational study with the primary end-point "CMR-based diagnosis of cardial amyloidosis"	—

Countries

Germany

Contacts

Public ContactAli Yilmaz

Klinik für Kardiologie I, Universitätsklinikum Münster

ali.yilmaz@ukmuenster.de0215 83 45185

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026